HopeStage
Study directory

Depression studies

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

Back to overview
More filters: keywords, city, remote
1491studies shown
Showing 13-24 of 1,491
Device study icon
RecruitingNCT07474974

ipRGC as a Potential Biomarker for Predicting Transcranial Magnetic Stimulation Treatment Response in Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Porto
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Portugal
Sponsor
Polytechnic Institute of Porto
Condition
Depression
Drug study icon
RecruitingNCT05973851

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

The registry lists this study as recruiting. Study locations are listed in the United Kingdom, in Austria, in Germany, ...

Multiple locations, including Innsbruck
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom, Austria, Germany, ...
Sponsor
Dr. Inge Winter
Condition
Depression
Drug study icon
RecruitingNCT07569198

Ketamine With Dialectical Behavioural Therapy (DBT) for Suicide prevention in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

The registry lists this study as recruiting. Study locations are listed in Canada.

In Toronto
Why is this study shown?

This study is directly about Depression.

Depression, Personality disorders, ...DrugFrom 18 Years to 70 Years
Countries
Canada
Sponsor
Joshua Rosenblat
Condition
Depression, Personality disorders, ...
Drug study icon
RecruitingNCT06132178

Psilocybin rTMS for Treatment Resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Austin
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 22 Years to 65 Years
Countries
United States
Sponsor
University of Texas at Austin
Condition
Depression
Drug study icon
RecruitingNCT07196501

Maintenance Effect of Osavampator for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Multiple locations, including Oceanside
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Australia, Canada, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Device study icon
RecruitingNCT07603804

Accelerated iTBS for Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Istanbul
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 65 Years
Countries
Türkiye
Sponsor
Istanbul University - Cerrahpasa
Condition
Depression
Drug study icon
RecruitingNCT07696871

Cannabidiol Oil for Treatment-Resistant Major Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Tubarão
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 69 Years
Countries
Brazil
Sponsor
Universidade do Sul de Santa Catarina
Condition
Depression
Drug study icon
RecruitingNCT06966401

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06911112

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Lithuania, ...

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Bulgaria, Lithuania, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06963021

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Multiple locations, including Chino
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Neurocrine Biosciences
Condition
Depression
Drug study icon
RecruitingNCT06786624

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.